[go: up one dir, main page]

BRPI0508933A - composições para entrega tópica - Google Patents

composições para entrega tópica

Info

Publication number
BRPI0508933A
BRPI0508933A BRPI0508933-6A BRPI0508933A BRPI0508933A BR PI0508933 A BRPI0508933 A BR PI0508933A BR PI0508933 A BRPI0508933 A BR PI0508933A BR PI0508933 A BRPI0508933 A BR PI0508933A
Authority
BR
Brazil
Prior art keywords
compositions
treatment
topical delivery
present
administration
Prior art date
Application number
BRPI0508933-6A
Other languages
English (en)
Inventor
Rajesh Jain
Kuor Chand Jindal
Sukhjeet Singh
Vaibhav Sihorkar
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of BRPI0508933A publication Critical patent/BRPI0508933A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçõES PARA ENTREGA TóPICA. A presente invenção refere-se a composições farmacêuticas para administração tópica que compreendendo pelo menos um ingrediente ativo, seus sais, ésteres, hidratos ou derivados, um sistema gelificador que consistindo em um campo de tensoativo, um sistema de solvente compreendendo pelo menos um componente oleoso, uma fase aquosa, que contém opcionalmente um ou mais agentes estabilizantes, e outros excipientes farmaceuticamente aceitáveis, e processo para preparar tais composições. Também se proporciona um método para a administração/tratamento de infecções fungosas, bacterianas e microbianas, inflamações, condições autoimunes, ou disturbios hormonais que compreende administrar uma quantidade farmaceuticamente eficaz de tal composição farmacêutica em um indivíduo necessitado de tal tratamento. As composições da presente invenção são não-gordurosas e facilmente laváveis com água, e proporcionam uma localização aumentada de ingredientes ativos hidrofóbicos e/ou anfifílicos sobre a pele.
BRPI0508933-6A 2004-03-18 2005-03-17 composições para entrega tópica BRPI0508933A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN501DE2004 2004-03-18
PCT/IN2005/000086 WO2005087195A2 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery

Publications (1)

Publication Number Publication Date
BRPI0508933A true BRPI0508933A (pt) 2007-08-14

Family

ID=34976285

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508933-6A BRPI0508933A (pt) 2004-03-18 2005-03-17 composições para entrega tópica

Country Status (10)

Country Link
US (1) US20080050434A1 (pt)
EP (1) EP1734925A2 (pt)
AP (1) AP2006003784A0 (pt)
AU (1) AU2005221427B2 (pt)
BR (1) BRPI0508933A (pt)
CA (1) CA2559351A1 (pt)
EA (1) EA011244B1 (pt)
RS (1) RS20060479A (pt)
WO (1) WO2005087195A2 (pt)
ZA (1) ZA200608621B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297215B6 (cs) * 2005-04-06 2006-10-11 Zentiva, A. S. Topická léková forma s obsahem nimesulidu
MXPA05010457A (es) * 2005-09-28 2007-03-27 Fernando Ahumada Ayala Preparacion para el tratamiento de enfermedades inflamatorias de la piel, que contiene tacrolimus.
US7931911B2 (en) * 2006-04-07 2011-04-26 Riken Pesticidal/ovicidal composition and pesticidal/ovicidal method
DK2167033T3 (en) 2007-05-30 2017-08-14 Veloxis Pharmaceuticals As Once daily oral dosage form comprising tacrolism
US12083103B2 (en) 2007-05-30 2024-09-10 Veloxis Pharmaceuticals, Inc. Tacrolimus for improved treatment of transplant patients
WO2008154368A2 (en) * 2007-06-08 2008-12-18 University Of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
WO2009010986A1 (en) * 2007-07-19 2009-01-22 Glenmark Pharmaceuticals Limited Topical cream compositions of sertaconazole nitrate
US12403095B2 (en) 2008-05-30 2025-09-02 Veloxis Pharmaceuticals, Inc. Stabilized tacrolimus composition
MX2011000932A (es) 2008-07-23 2011-05-19 Targeted Delivery Technologies Ltd Metodos para administrar formulaciones antifungicas topicas para el tratamiento de infecciones fungicas.
ES2478845T3 (es) * 2008-10-08 2014-07-23 Takata Seiyaku Co., Ltd. Preparación de tacrolimus para aplicaciones externas
WO2010109425A2 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal steroids cream and a process to make it
WO2010109418A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal cream and a process to make it
WO2010119365A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using clotrimazole and chitosan and a process to make the same
WO2010119387A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same
WO2010119368A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same
WO2010119386A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using clotrimazole, fluticasone propionate, and chitosan, and a process to make the same
WO2011027246A1 (en) * 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi A cream comprising miconazole nitrate and a biopolymer for the treatment of diaper rash
WO2011027247A1 (en) * 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
MX2012003987A (es) * 2009-10-02 2012-07-30 Yissum Res Dev Co Composiciones desinfectantes.
EP2575769B1 (en) 2010-02-17 2016-06-15 Veloxis Pharmaceuticals A/S Stabilized tacrolimus composition
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
US11806427B2 (en) * 2014-09-17 2023-11-07 Alps South Europe, S.R.O. Topical composition containing antioxidants
WO2016077556A1 (en) * 2014-11-12 2016-05-19 Research Foundation Of The City University Of New York Environmentally friendly gelator using medium chain triglycerides and method of use
WO2016094617A1 (en) * 2014-12-11 2016-06-16 Phosphorex, Inc. Aqueous topical drug formulation with controlled release and increased stability
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
AU2016263161B2 (en) 2015-05-21 2019-02-28 Dermavant Sciences GmbH Topical pharmaceutical compositions
CN106967536B (zh) * 2017-03-29 2019-04-02 东北石油大学 砂岩类原油驱替实验岩心洗油剂及其制备方法
CN113440483B (zh) * 2021-06-30 2023-04-07 佛山市南海东方澳龙制药有限公司 一种犬用盐酸特比萘芬喷剂及其制备方法
CN116077421B (zh) * 2023-01-03 2023-12-12 江苏知原药业股份有限公司 一种他克莫司软膏及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1593697A (en) * 1996-01-23 1997-08-20 Chemisch Adviesbureau Drs J.C.P.Schreuder B.V. Composition for treating skin affections and process for its preparation
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent

Also Published As

Publication number Publication date
AU2005221427A1 (en) 2005-09-22
EP1734925A2 (en) 2006-12-27
ZA200608621B (en) 2008-06-25
EA200601724A1 (ru) 2007-02-27
RS20060479A (sr) 2008-11-28
EA011244B1 (ru) 2009-02-27
US20080050434A1 (en) 2008-02-28
WO2005087195A2 (en) 2005-09-22
WO2005087195A3 (en) 2006-08-03
CA2559351A1 (en) 2005-09-22
AP2006003784A0 (en) 2006-10-31
AU2005221427B2 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
BRPI0508933A (pt) composições para entrega tópica
Garg et al. Comprehensive review on additives of topical dosage forms for drug delivery
RU2468794C2 (ru) Фармацевтическая композиция для топического применения
KR101517494B1 (ko) 디클로페낙의 신규한 비수용성 국소 용액 및 이를 제조하는 과정
JP6283392B2 (ja) 勃起不全および他の適応症の処置
ES2599973T3 (es) Una formulación tópica de propionato de clobetasol de nivel bajo para tratar trastornos de la membrana mucosa y de la piel
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
US9289495B2 (en) Systems and methods for treatment of allergies and other indications
JP2016513690A (ja) シルデナフィルおよび他のホスホジエステラーゼ５阻害剤の経皮送達
RU2012149863A (ru) Полисахарид семени тамаринда для применения в лечении микробных инфекций
CN105209051A (zh) 痤疮溶液
US20200301526A1 (en) Novel non-aqueous topical solution of diclofenac and process for preparing the same
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
AR107212A1 (es) Compuestos tópicos de matriz polimérica que comprenden una alta concentración de hialuronato de sodio biofermentado y sus usos
CN107249573A (zh) 局部药物制剂
WO2014042604A1 (en) Clindamycin phosphate, salicylic acid and tea tree oil combinations
ES2880437T3 (es) Nuevas composiciones tópicas que comprenden ácido úsnico y su uso terapéutico
JP6903411B2 (ja) 外用組成物
ES2645999T3 (es) Veneno paralizante de mariscos para el tratamiento del picor
US20160184331A1 (en) Base and external preparation for skin
JP2016513686A (ja) フルチカゾンの経皮製剤
WO2006091719A3 (en) Compositions and methods enhancing transdermal delivery of drugs and biologics
CN118401238A (zh) 痤疮用外用组合物和痤疮丙酸杆菌选择性抗菌/杀菌用外用组合物
US20140135363A1 (en) Proton pump inhibitor for use in a method of treating dermatological diseases in canine
US20250099369A1 (en) Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.